This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignees: Intocell, Inc., Y-Biologics Inc.. Active years: 2024-2026.
Company Filing History:
2 out of 8 
1 out of 12 Years Active: 2024-2026
Title: Jina Song: Innovator in Antibody-Drug Conjugates
Introduction
Jina Song is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates.
Latest Patents
Jina Song holds 1 patent for her work on antibody-drug conjugates comprising anti-B7-H3 antibodies. The patent details a novel approach where one or more active agents are conjugated to an anti-B7-H3 antibody through a linker. This linker is designed to covalently link active agents to the antibody. The patent also discusses monoclonal antibodies and various forms that specifically bind to B7-H3, along with methods for their therapeutic, diagnostic, and prophylactic applications.
Career Highlights
Throughout her career, Jina has worked with notable companies such as Intocell, Inc. and Y-Biologics Inc. Her innovative work has positioned her as a key figure in the biotechnology sector.
Collaborations
Jina has collaborated with talented individuals, including Taekyo Park and Sunyoung Kim, who have contributed to her research and development efforts.
Conclusion
Jina Song's contributions to the field of antibody-drug conjugates highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic options.